A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder

GSK Investigational Site, New York

GSK Investigational Site, The Bronx

GSK Investigational Site, Maitland

GSK Investigational Site, Orlando

GSK Investigational Site, North Miami

GSK Investigational Site, Bradenton

GSK Investigational Site, Birmingham

GSK Investigational Site, Toledo

GSK Investigational Site, Middleton

GSK Investigational Site, Overland Park

GSK Investigational Site, Scottsdale

GSK Investigational Site, Beverly Hills

GSK Investigational Site, Arcadia

GSK Investigational Site, Upland

GSK Investigational Site, National City

GSK Investigational Site, Seattle

GSK Investigational Site, Lincoln

GSK Investigational Site, Burlington

GSK Investigational Site, Ottawa

GSK Investigational Site, Toronto